{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:45:24Z","timestamp":1790847924323,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015308","name":"Stephenson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015308","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ygyno.2020.09.002","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T13:17:59Z","timestamp":1600435079000},"page":"563-572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration"],"prefix":"10.1016","volume":"159","author":[{"given":"Gokhan","family":"Gunay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande A.","family":"Kirit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Advika","family":"Kamatar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofelya","family":"Baghdasaryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seren","family":"Hamsici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handan","family":"Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ygyno.2020.09.002_bb0005","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018: ovarian Cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.002_bb0010","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2020.09.002_bb0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research","volume":"13","author":"Kipps","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2020.09.002_bb0020","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/annonc\/mdl499","article-title":"Pattern and prognostic factors in patients with malignant ascites: a retrospective study","volume":"18","author":"Ayantunde","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2020.09.002_bb0025","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1038\/s41388-018-0317-x","article-title":"Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer","volume":"37","author":"Al Habyan","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2020.09.002_bb0030","article-title":"Knock-down of P-glycoprotein reverses taxol resistance in ovarian cancer multicellular spheroids","volume":"1","author":"Xing","year":"2007","journal-title":"Oncol Rep [Internet]"},{"key":"10.1016\/j.ygyno.2020.09.002_bb0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1479-5876-4-6","article-title":"Disaggregation and invasion of ovarian carcinoma ascites spheroids","volume":"4","author":"Burleson","year":"2006","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2020.09.002_bb0040","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/089686080602600207","article-title":"Peritoneal mesothelial cell culture and biology","volume":"26","author":"Yung","year":"2006","journal-title":"Perit. Dial. Int."},{"issue":"4","key":"10.1016\/j.ygyno.2020.09.002_bb0045","first-page":"194","article-title":"Isolation and morphologic characterization of human ovarian carcinoma cell clusters present in effusions","volume":"55","author":"Allen","year":"1987","journal-title":"Exp Cell Biol."},{"key":"10.1016\/j.ygyno.2020.09.002_bb0050","doi-asserted-by":"crossref","unstructured":"Latifi A, Luwor RB, Bilandzic M, Nazaretian S, Stenvers K, Pyman J, et al. Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors. Hawkins SM, PLoS ONE. 2012 Oct 8;7(10):e46858.","DOI":"10.1371\/journal.pone.0046858"},{"issue":"5","key":"10.1016\/j.ygyno.2020.09.002_bb0055","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-Mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell."},{"key":"10.1016\/j.ygyno.2020.09.002_bb0060","series-title":"Progress in Molecular Biology and Translational Science [Internet]","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/B978-0-12-394311-8.00014-5","article-title":"Cadherins and epithelial-to-mesenchymal transition","author":"Gheldof","year":"2013"},{"issue":"1\u20133","key":"10.1016\/j.ygyno.2020.09.002_bb0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000101307","article-title":"Epithelial-Mesenchymal transition in ovarian Cancer progression: a crucial role for the Endothelin Axis","volume":"185","author":"Bagnato","year":"2007","journal-title":"Cells Tissues Organs"},{"issue":"Pt 4","key":"10.1016\/j.ygyno.2020.09.002_bb0070","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1242\/jcs.114.4.629","article-title":"The cadherin superfamily: diversity in form and function","volume":"114","author":"Angst","year":"2001","journal-title":"J. Cell Sci."},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.002_bb0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00441-005-0148-2","article-title":"Dynamic analysis of hepatoma spheroid formation: roles of E-cadherin and \u03b21-integrin","volume":"324","author":"Lin","year":"2006","journal-title":"Cell Tissue Res."},{"issue":"23","key":"10.1016\/j.ygyno.2020.09.002_bb0080","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1007\/s00018-008-8281-1","article-title":"The cell-cell adhesion molecule E-cadherin","volume":"65","author":"van Roy","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.ygyno.2020.09.002_bb0085","first-page":"255","article-title":"Ovarian surface epithelium: biology, endocrinology, and pathology 1","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.ygyno.2020.09.002_bb0090","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1096\/fj.09-151639","article-title":"Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition","volume":"24","author":"Mendez","year":"2010","journal-title":"FASEB J."},{"issue":"Pt 13","key":"10.1016\/j.ygyno.2020.09.002_bb0095","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1242\/jcs.111.13.1897","article-title":"Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts","volume":"111","author":"Eckes","year":"1998","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ygyno.2020.09.002_bb0100","article-title":"The role of Vimentin intermediate filaments in the progression of lung Cancer","volume":"27","author":"Kidd","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"6","key":"10.1016\/j.ygyno.2020.09.002_bb0105","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10585-008-9171-5","article-title":"Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression","volume":"25","author":"Hudson","year":"2008","journal-title":"Clin Exp Metastasis."},{"issue":"3","key":"10.1016\/j.ygyno.2020.09.002_bb0110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jcp.21240","article-title":"Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm","volume":"213","author":"Ahmed","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ygyno.2020.09.002_bb0115","series-title":"Stelzer EHK","author":"Pampaloni","year":"2007"},{"key":"10.1016\/j.ygyno.2020.09.002_bb0120","series-title":"Ingber DE","author":"Sontheimer-Phelps","year":"2019"},{"issue":"6","key":"10.1016\/j.ygyno.2020.09.002_bb0125","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0002-9440(10)63058-1","article-title":"Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids","volume":"159","author":"Casey","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2020.09.002_bb0130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3389\/fphys.2017.00605","article-title":"Comparative analysis of 3D bladder tumor spheroids obtained by forced floating and hanging drop methods for drug screening","volume":"8","author":"Amaral","year":"2017","journal-title":"Front. Physiol."},{"issue":"11","key":"10.1016\/j.ygyno.2020.09.002_bb0135","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.1073\/pnas.96.11.6249","article-title":"E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium","volume":"96","author":"Auersperg","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.002_bb0140","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ygyno.2004.03.037","article-title":"Immunohistochemical patterns for \u03b1- and \u03b2-catenin, E- and N-cadherin expression in ovarian epithelial tumors","volume":"94","author":"Marques","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.002_bb0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2559.1998.00341.x","article-title":"Ponder. Expression of E-cadherin, \u03b1-catenin and \u03b2-catenin in normal ovarian surface epithelium and epithelial ovarian cancers","volume":"32","author":"Davies","year":"1998","journal-title":"Histopathology."},{"issue":"22","key":"10.1016\/j.ygyno.2020.09.002_bb0150","article-title":"Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease","volume":"7","author":"Haley","year":"2016","journal-title":"Oncotarget [Internet]"},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.002_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jbiotec.2010.01.012","article-title":"Multicellular tumor spheroids: an underestimated tool is catching up again","volume":"148","author":"Hirschhaeuser","year":"2010","journal-title":"J. Biotechnol."},{"issue":"5","key":"10.1016\/j.ygyno.2020.09.002_bb0160","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1158\/0008-5472.CAN-14-2611","article-title":"Novel morphologic and genetic analysis of Cancer cells in a 3D microenvironment identifies STAT3 as a regulator of tumor permeability barrier function","volume":"76","author":"Park","year":"2016","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.002_bb0165","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2015.04.014","article-title":"Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays","volume":"138","author":"Takayama","year":"2015","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.ygyno.2020.09.002_bb0170","doi-asserted-by":"crossref","first-page":"16948","DOI":"10.18632\/oncotarget.7659","article-title":"Comparative analysis of tumor spheroid generation techniques for differential in vitro drug toxicity","volume":"7","author":"Horst","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.002_bb0175","doi-asserted-by":"crossref","first-page":"6837","DOI":"10.1038\/s41598-018-25203-3","article-title":"Facile tumor spheroids formation in large quantity with controllable size and high uniformity","volume":"8","author":"Shi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygyno.2020.09.002_bb0180","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2016.03.013","article-title":"Three-dimensional culture systems in cancer research: focus on tumor spheroid model","volume":"163","author":"Nath","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ygyno.2020.09.002_bb0185","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jbiotec.2016.01.031","article-title":"Adaptable stirred-tank culture strategies for large scale production of multicellular spheroid-based tumor cell models","volume":"221","author":"Santo","year":"2016","journal-title":"J. Biotechnol."},{"issue":"5","key":"10.1016\/j.ygyno.2020.09.002_bb0190","doi-asserted-by":"crossref","DOI":"10.2310\/7290.2008.00023","article-title":"Optimizing imaging of three-dimensional multicellular tumor spheroids with fluorescent reporter proteins using confocal microscopy","volume":"7","author":"le Roux","year":"2008","journal-title":"Mol. Imaging"},{"issue":"5","key":"10.1016\/j.ygyno.2020.09.002_bb0195","doi-asserted-by":"crossref","DOI":"10.1063\/1.5020249","article-title":"Three dimensional live-cell STED microscopy at increased depth using a water immersion objective","volume":"89","author":"Heine","year":"2018","journal-title":"Rev. Sci. Instrum."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.002_bb0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1476-4598-10-139","article-title":"SLUG promotes prostate cancer cell migration and invasion via CXCR4\/CXCL12 axis","volume":"10","author":"Uygur","year":"2011","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.002_bb0205","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ygyno.2020.09.002_bb0210","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/biology3020345","article-title":"Advanced cell culture techniques for Cancer drug discovery","volume":"3","author":"Lovitt","year":"2014","journal-title":"Biology."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.002_bb0215","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ygyno.2005.02.006","article-title":"An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines","volume":"98","author":"Smith","year":"2005","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.002_bb0220","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/gyno.1994.1085","article-title":"Evaluation of paclitaxel (Taxol), Cisplatin, and the combination paclitaxel-Cisplatin in ovarian Cancer in vitro with the ATP cell viability assay","volume":"53","author":"Untch","year":"1994","journal-title":"Gynecol. Oncol."},{"issue":"17","key":"10.1016\/j.ygyno.2020.09.002_bb0225","first-page":"1320","article-title":"A randomized clinical trial of Cisplatin\/paclitaxel versus carboplatin\/paclitaxel as first-line treatment of ovarian Cancer","volume":"95","author":"du Bois","year":"2003","journal-title":"CancerSpectrum Knowledge Environment."},{"issue":"12","key":"10.1016\/j.ygyno.2020.09.002_bb0230","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/bjc.2012.207","article-title":"In vitro analysis of ovarian cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival","volume":"106","author":"Bicaku","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.002_bb0235","doi-asserted-by":"crossref","first-page":"9529","DOI":"10.1038\/srep09529","article-title":"Alterations in ovarian Cancer cell adhesion drive Taxol resistance by increasing microtubule dynamics in a FAK-dependent manner","volume":"5","author":"McGrail","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.002_bb0240","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/toxsci\/kfs085","article-title":"Sodium Arsenite \u00b1 hyperthermia sensitizes p53-expressing human ovarian Cancer cells to Cisplatin by modulating platinum-DNA damage responses","volume":"127","author":"Muenyi","year":"2012","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ygyno.2020.09.002_bb0245","series-title":"In vitro 3D Spheroids and Microtissues: ATP-based Cell Viability and Toxicity Assays","author":"Kijanska","year":"2004"},{"key":"10.1016\/j.ygyno.2020.09.002_bb0250","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fonc.2017.00293","article-title":"High-content monitoring of drug effects in a 3D spheroid model","volume":"7","author":"Mittler","year":"2017","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2020.09.002_bb0255","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1091\/mbc.10.4.947","article-title":"Taxol suppresses dynamics of individual microtubules in living human tumor cells. Kirschner MW, editor","volume":"10","author":"Yvon","year":"1999","journal-title":"MBoC."},{"key":"10.1016\/j.ygyno.2020.09.002_bb0260","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ygyno.2020.09.002_bb0265","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3109\/07357909809039774","article-title":"The morphogenetic role of cadherin cell adhesion molecules in human Cancer: a thematic review","volume":"16","author":"Yap","year":"1998","journal-title":"Cancer Investig."},{"key":"10.1016\/j.ygyno.2020.09.002_bb0270","doi-asserted-by":"crossref","first-page":"e0184439","DOI":"10.1371\/journal.pone.0184439","article-title":"E-cadherin: a determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness","volume":"9","author":"Rosso","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2020.09.002_bb0275","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.442","article-title":"An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)","volume":"4","author":"Huang","year":"2013","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.002_bb0280","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3892\/ijo.2014.2695","article-title":"Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers","volume":"46","author":"Yi","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2020.09.002_bb0285","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1172\/JCI69815","article-title":"Mesenchymal gene program\u2013expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance","volume":"124","author":"Davidowitz","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.ygyno.2020.09.002_bb0290","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/sj.bjc.6603533","article-title":"Expression of twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients","volume":"96","author":"Hosono","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.ygyno.2020.09.002_bb0295","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1002\/ijc.24901","article-title":"Snail is critical for tumor growth and metastasis of ovarian carcinoma","volume":"126","author":"Jin","year":"2010","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.002_bb0300","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3747\/co.19.895","article-title":"Understanding and overcoming chemoresistance in ovarian cancer: emerging role of the endothelin axis","volume":"19","author":"Bagnato","year":"2012","journal-title":"Curr. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2020.09.002_bb0305","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/1933719116654989","article-title":"Slug is associated with tumor metastasis and angiogenesis in ovarian Cancer","volume":"24","author":"Gu","year":"2017","journal-title":"Reprod. Sci."},{"issue":"4","key":"10.1016\/j.ygyno.2020.09.002_bb0310","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3892\/ijo.2015.2878","article-title":"Slug contributes to cancer progression by direct regulation of ER\u03b1 signaling pathway","volume":"46","author":"Li","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2020.09.002_bb0315","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2004.12.043","article-title":"K a, Bapat SA. Snail and slug are major determinants of ovarian cancer invasiveness at the transcription level","volume":"97","author":"Kurrey","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2020.09.002_bb0320","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2017.5259","article-title":"Effects of CD44 and E-cadherin overexpression on the proliferation, adhesion and invasion of ovarian cancer cells","author":"Mao","year":"2017","journal-title":"Exp Ther Med [Internet]"},{"issue":"15","key":"10.1016\/j.ygyno.2020.09.002_bb0325","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1158\/0008-5472.CAN-17-3993","article-title":"Licofelone enhances the efficacy of paclitaxel in ovarian Cancer by reversing drug resistance and tumor stem-like properties","volume":"78","author":"Hirst","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2020.09.002_bb0330","doi-asserted-by":"crossref","unstructured":"DesRochers TM, Suter L, Roth A, Kaplan DL. Bioengineered 3D Human Kidney Tissue, a Platform for the Determination of Nephrotoxicity. Egles C, PLoS ONE. 2013 Mar 14;8(3):e59219.","DOI":"10.1371\/journal.pone.0059219"},{"key":"10.1016\/j.ygyno.2020.09.002_bb0335","doi-asserted-by":"crossref","unstructured":"Chowanadisai W, Messerli SM, Miller DH, Medina JE, Hamilton JW, Messerli MA, et al. Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors. Orsulic S, PLoS ONE. 2016 Mar 17;11(3):e0151089.","DOI":"10.1371\/journal.pone.0151089"},{"issue":"7","key":"10.1016\/j.ygyno.2020.09.002_bb0340","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1073\/pnas.89.7.3070","article-title":"High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis","volume":"89","author":"Godwin","year":"1992","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820338579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825820338579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T08:06:06Z","timestamp":1715846766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825820338579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0090825820338579"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.09.002","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2020.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}